Phentolamine Mesilate

甲磺酸酚妥拉明

Report date: 2025/06/09 13:58:34
NME

Base Information

Drug NamePhentolamine Mesilate
Drug Alias Name酚妥拉明甲磺酸盐FentolaminaPhentolamine MesylatePhentolaminumPhentolamine +[12] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptors antagonists
TargetsAdrenergic receptors
Therapy Area/IndicationsSoft Tissue InjuriesNarcotic-Related DisordersDrug-Related Side Effects and Adverse Reactions +[12] 
Global Approved IndicationsNarcotic-Related DisordersErectile Dysfunction
Approved Indications in ChinaErectile Dysfunction
Original Approved Country/TerritoryN/A
Original Approved Date1951/01/01
Country/TerritoryUnited StatesEgyptMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesFamyGen Life Sciences IncCairo UniversitySeptodont Inc +[9] 
Inactive CompaniesNovalar Pharmaceuticals IncBeijing Furuikangzheng Medicine Technology Research Institute
Active IndicationsSoft Tissue InjuriesNarcotic-Related DisordersDrug-Related Side Effects and Adverse Reactions +[11] 
Inactive IndicationsAnesthesia

Other Information

ATC CodeC04AB01V03AB36
Related LinksWikipediaDrugBankKEGG